“A second version of the EudraPharm database of information on medicinal products approved within the European Union has been released today. The main new benefits of this update are: Inclusion of product information documents in all available EU languages, Inclusion of maximum-residue-limit information for veterinary products, Inclusion of an advanced search function to make information searches more accurate, Inclusion of a new site map to improve navigation. EudraPharm is a long-term project being funded by the European Commission and implemented by the EMEA [European Agency for the Evaluation of Medicinal Products], in close cooperation with the medicines agencies of each EU Member State, to provide information about all medicines for human or veterinary use authorised in the EU.”
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment